Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Folegatti PM"'
Autor:
Swanson, PA, Padilla, M, Hoyland, W, McGlinchey, K, Fields, PA, Bibi, S, Faust, SN, McDermott, AB, Lambe, T, Pollard, AJ, Durham, NM, Kelly, EJ, AstraZeneca/Oxford/VRC Study Group, Adlou, S, Aley, PK, Angus, B, Anslow, R, Baker, P, Bansal, H, Beveridge, A, Bridges-Webb, A, Ching, S, Cicconi, P, Clutterbuck, EA, Collins, AM, Darton, TC, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Ewer, KJ, Felle, S, Ferreira, DM, Folegatti, PM, Fuskova, M, Gaudinski, M, Gilbert, SC, Goodman, AL, Gordon, I, Green, CA, Harbolick, E, Hayes, S, Hill, AVS, Hill, H, Jenkin, D, Jepson, BM, Kasanyinga, M, Libri, V, Lillie, PJ, McGregor, AC, Minassian, AM, Mujadidi, YF, Novik, L, Payne, R, Pilataxi, F, Plested, E, Provstgaard-Morys, S, Ramasamy, M, Robinson, H, Sanders, K, Smith, A, Snape, MD, Song, R, Sutherland, RK, Thomson, EC, Toshner, M, Turner, DPJ, Voysey, M, Widge, AT, Williams, CJ
AZD1222 (ChAdOx1 nCoV-19), a replication-deficient simian adenovirus-vectored vaccine, has demonstrated safety, efficacy, and immunogenicity against coronavirus disease 2019 (COVID-19) in clinical trials and real-world studies. We characterized CD4+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::993e6e80c4502ef8c2b6b487068309ee
https://eprints.whiterose.ac.uk/178925/1/scitranslmed.abj7211.pdf
https://eprints.whiterose.ac.uk/178925/1/scitranslmed.abj7211.pdf
Autor:
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M, Adlou, S, Allen, L, Angus, B, Anslow, R, Asselin, M-C, Baker, N, Baker, P, Barlow, T, Beveridge, A, Bewley, KR, Brown, P, Brunt, E, Buttigieg, KR, Camara, S, Charlton, S, Chiplin, E, Cicconi, P, Clutterbuck, EA, Collins, AM, Coombes, NS, Clemens, SAC, Davison, M, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Emary, KRW, Ewer, KJ, Felle, S, Ferreira, DM, Finn, A, Folegatti, PM, Fothergill, R, Fraser, S, Garlant, H, Gatcombe, L, Godwin, KJ, Goodman, AL, Green, CA, Hallis, B, Hart, TC, Heath, PT, Hill, H, Hill, AVS, Jenkin, D, Kasanyinga, M, Kerridge, S, Knight, C, Leung, S, Libri, V, Lillie, PJ, Marinou, S, McGlashan, J, McGregor, AC, McInroy, L, Minassian, AM, Mujadidi, YF, Penn, EJ, Petropoulos, CJ, Pollock, KM, Proud, PC, Provstgaard-Morys, S, Rajapaska, D, Ramasamy, MN, Sanders, K, Shaik, I, Singh, N, Smith, A, Snape, MD, Song, R, Shrestha, S, Sutherland, RK, Thomson, EC, Turner, DPJ, Webb-Bridges, A, Wrin, T, Williams, CJ
Publikováno v:
Nature Medicine
The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222)
Autor:
Folegatti, PM, Harrison, K, Lopez, KR, Tilley, MW, Lopez-Camacho, C, Kim, YC, Preciado-Llanes, L, Rossi, SL, Poulton, I, Jenkin, D, Datoo, M, Themistocleous, Y, Lawrie, A, Roberts, R, Ewer, K, Berrie, E, Hill, A, Reyes-Sandoval, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::9ff9e00c9b540c24efac4a6e902d08a5
https://doi.org/10.4269/ajtmh.abstract2019
https://doi.org/10.4269/ajtmh.abstract2019
Autor:
Coughlan, L, Sridhar, S, Payne, R, Edmans, E, Milicic, A, Venkatraman, N, Lugonja, B, Clifton, L, Qi, C, McMichael, A, Folegatti, PM, Lawrie, AM, Roberts, R, de Graaf, H, Sukhtankar, P, Faust, SN, Lewis, DJM, Lambe, T, Hill, AVS, Gilbert, SC
Publikováno v:
EBioMedicine, Vol 29, Iss, Pp 146-154 (2018)
EBioMedicine
EBioMedicine
Background T-cell responses against highly conserved influenza antigens have been previously associated with protection. However, these immune responses are poorly maintained following recovery from influenza infection and are not boosted by inactiva
Autor:
Venkatraman, N, Bowyer, G, Edwards, NJ, Griffiths, O, Powlson, J, Silman, D, Morter, R, Folegatti, PM, Minassian, AM, Poulton, ID, Collins, K, Brod, F, Angell-Manning, P, Berrie, E, Brendish, N, Glenn, G, Fries, L, Baum, J, Blagborough, AM, Roberts, R, Lawrie, AM, Lewis, DJ, Faust, SN, Gilbert, S, Ewer, KJ, Hill, AV
It remains a global health priority to develop a durable and highly efficacious malaria vaccine. The most advanced malaria vaccine candidate, RTS,S/AS01 has completed Phase III testing in a multicentre study across several African sites and demonstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::cdeff7a19e2b23f37f8e072d98cfab76
https://ora.ox.ac.uk/objects/uuid:e433efac-8e80-4278-b303-3537df06b9f7
https://ora.ox.ac.uk/objects/uuid:e433efac-8e80-4278-b303-3537df06b9f7
Autor:
Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Platt A; The Jenner Institute, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK., Tran N; The Jenner Institute, University of Oxford, Oxford, UK., Boyd A; The Jenner Institute, University of Oxford, Oxford, UK., Turner C; The Jenner Institute, University of Oxford, Oxford, UK., Gitonga JN; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Bowden TA; Wellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, Oxford, UK., Gilbert SC; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Charleston B; The Pirbright Institute, Pirbright, UK., Kaleebu P; Medical Research Council-Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK., Warimwe GM; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. Electronic address: gwarimwe@kemri-wellcome.org.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 956-964. Date of Electronic Publication: 2023 Apr 13.
Autor:
Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Flaxman A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aboagye J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Bittaye M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cappuccini F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Charlton S; Public Health England, Porton Down, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Davies S; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Edwards NJ; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fowler J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbride C; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Godfrey L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hallis B; Public Health England, Porton Down, UK., Humphries HE; Public Health England, Porton Down, UK., Jenkin D; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sanders H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Thomas KM; Public Health England, Porton Down, UK., Ulaszewska M; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Woods D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Wright D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 24; Vol. 211 (3), pp. 280-287.
Autor:
Salkeld J; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Barrett JR; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Mitton CH; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Rawlinson TA; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Hou MM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Khozoee B; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Sandoval DM; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Bach FA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Nahrendorf W; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Ramon RL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Baker M; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ramos-Lopez F; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ellis KJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Poulton ID; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Cho JS; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nugent FL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom., Silk SE; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Minassian AM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 22; Vol. 13, pp. 984323. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).
Autor:
Folegatti PM; University of Oxford, Oxford, United Kingdom., Jenkin D; University of Oxford, Oxford, United Kingdom., Morris S; University of Oxford, Oxford, United Kingdom., Gilbert S; University of Oxford, Oxford, United Kingdom., Kim D; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Robertson JS; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Martin E; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.
Publikováno v:
Vaccine [Vaccine] 2022 Aug 19; Vol. 40 (35), pp. 5248-5262. Date of Electronic Publication: 2022 Jun 14.
Autor:
Ratcliff J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Al-Beidh F; Imperial College London, London, United Kingdom.; Imperial College Health NHS Trust, St. Mary's Hospital, London, United Kingdom., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Bonsall D; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Costa Clemens SA; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Institute for Global Health, University of Siena, Siena, Italy., Estcourt L; Haematology Theme, Radcliffe Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Evans A; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Fish M; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Folegatti PM; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Gordon AC; Imperial College London, London, United Kingdom.; Imperial College Health NHS Trust, St. Mary's Hospital, London, United Kingdom., Jay C; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Jennings A; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Laing E; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Lambe T; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxfordgrid.4991.5, Oxford, United Kingdom., MacIntyre-Cockett G; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Menon D; University Division of Anaesthesia, University of Cambridgegrid.5335.0, Cambridge, United Kingdom., Mouncey PR; Intensive Care National Audit and Research Centre, London, United Kingdom., Nguyen D; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Roberts DJ; Haematology Theme, Radcliffe Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Clinical, Research, and Development, NHS Blood and Transport, Oxford, United Kingdom., Rowan KM; Intensive Care National Audit and Research Centre, London, United Kingdom., Rynne J; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Shankar-Hari M; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Williams S; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Harvala H; Microbiology Services, NHS Blood and Transport, London, United Kingdom., Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Simmonds P; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2022 Apr 20; Vol. 60 (4), pp. e0228321. Date of Electronic Publication: 2022 Mar 24.